David is a registered patent agent in Mintz’s San Diego office, where his practice focuses on patent prosecution and counseling in the life sciences, pharmaceuticals, health care, and renewable energy sectors. He advises private and public institutions of all sizes on IP strategy, portfolio growth, and asset management.

David brings extensive patent prosecution and portfolio management experience across a broad range of technologies, including adoptive cell therapies, antibody-based therapeutics, gene-based therapies, immuno-oncology, vaccines, personalized medicine, and molecular diagnostics. His practice also encompasses freedom-to-operate analysis, patentability assessment, IP due diligence, competitive landscape analysis, patent reissue, and inter partes review. Before joining Mintz, David served as a patent agent at a national IP and technology law firm, where he handled prosecution matters for international and domestic clients.

David also brings valuable in-house perspective from his roles as IP Manager at Synthetic Genomics, Inc. and as a patent agent at Ceres, Inc. (now Land O’Lakes, Inc.). These positions deepened his expertise in strategic IP procurement and patent portfolio management across agricultural sciences, plant breeding, agricultural microbiome technologies, synthetic biology, bio-based renewable chemicals, biofuels, and nutritional and food sciences.

David’s laboratory research experience spans biochemistry, virology, molecular biology, pathway engineering, genetics, and epigenetics. He held multiple R&D positions in the private biotech sector – including lead scientist, principal investigator, and R&D manager – and is particularly well-versed in recombinant technologies, genome engineering, high-throughput functional genomics, and genetically engineered crops.

David earned his doctorate at Paris-Saclay University and the French National Center for Scientific Research (CNRS), where he studied transcriptional control of eukaryotic gene expression. He completed postdoctoral research in virology as a visiting fellow at the National Institutes of Health (NIH).

David has co-authored scientific publications in major peer-reviewed journals and is a named inventor on twenty-six patents granted by the U.S. and Brazilian patent offices, with several additional applications pending in the United States and internationally.